Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Continuous processing optimization with smarter tools

Barbara Paldus, Ph.D.
Vice President & General Manager Finesse, part of Thermo Fisher Scientific

Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

Coupling single-pass TFF before loading onto a chromatography sorbent

View All Featured Articles

Headline News

Pfizer’s 25-valent pneumococcal vaccine shows robust immune responses in Phase II infant study

RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer

Incyte reports new KRAS G12D and bispecific antibody data across pancreatic and colorectal cancer

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Janssen CM-strategy: A Story of Multiple Platforms From R&D to Commercial

Presented by Jeroen Geens, Engineering Technical Director at Janssen Research & Development and Dr. Robin Meier, Manager Scientific Operations at L.B. Bohle Maschinen + Verfahren GmbH
03rd December 2020

Advances in Mass Spectrometry for the Analysis and Bioanalysis of Antibody Drug Conjugates

Presented by Arnaud Delobel, PhD, R&D Director at Quality Assistance sa
12th September 2017

Annex 1 and Environmental Monitoring Program – Implementation And Justification of The Best Practices In Routine

Presented by Presented by Benoit Ramond, Head of Microbiology & Sterile Technology at Sanofi and Laurent Leblanc, 3P Ecosytem R&D Manager at bioMérieux
19th October 2022

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos